KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash from Financing Activities (2016 - 2026)

Opko Health filings provide 17 years of Cash from Financing Activities readings, the most recent being -$5.2 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 28.22% to -$5.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$119.2 million, a 145.89% decrease, with the full-year FY2025 number at -$118.1 million, down 164.1% from a year prior.
  • Cash from Financing Activities hit -$5.2 million in Q1 2026 for Opko Health, up from -$18.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $224.6 million in Q3 2024 to a low of -$79.5 million in Q2 2025.
  • Median Cash from Financing Activities over the past 5 years was -$823000.0 (2023), compared with a mean of $9.5 million.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 10571.64% in 2024 and later tumbled 529.72% in 2025.
  • Opko Health's Cash from Financing Activities stood at $10.1 million in 2022, then plummeted by 136.98% to -$3.8 million in 2023, then surged by 6088.75% to $224.6 million in 2024, then plummeted by 108.16% to -$18.3 million in 2025, then skyrocketed by 71.88% to -$5.2 million in 2026.
  • The last three reported values for Cash from Financing Activities were -$5.2 million (Q1 2026), -$18.3 million (Q4 2025), and -$16.2 million (Q3 2025) per Business Quant data.